戻る Agenda
[S47] Toward to Development of Comprehensive and Reliable Drug Information System for Consumers and Patients
Session Chair(s)
Michiko Yamamoto, PhD
Visiting Professor
Kumamoto University, Japan
While pharmaceutical information is abundant on the media and the Internet, people do not know where they can obtain the correct information. When we evaluated medical information on the Internet based on international evaluation criteria etc., few sites met the criteria in Japan. It may be considered that the scheme for securing whether it is reliable information is not spreading. Pharmaceutical information does not provide sufficiently for the general public in the flow from clinical trial, approval to post-marketing. It is required to develop the comprehensive information infrastructure for shared decision making, considering the consumers and patients’ health literacy. It should be necessary to discuss the prospects and issues from the perspective of industry, government, academia and patients.
Speaker(s)
Medical Information: Evidence-Based Public Information and Shared Decision Making
Takeo Nakayama, MD, PhD
Kyoto University, Graduate School of Medicine and Faculty of Medicine, Japan
Professor, Department of Health Informatics, School of Public Health
Current Status and Future Prospects of Providing Information by Pharmaceutical Companies
Kazuhiro Keitoku
BeiGene Japan, Japan
Director, Head of Global Patient Safety, Japan
Toward Development of Comprehensive and Reliable Drug Information System for Consumers and Patients
Michiko Yamamoto, PhD
Kumamoto University, Japan
Visiting Professor